Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Effector Therapeutics Inc
(NQ:
EFTR
)
1.940
-0.040 (-2.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Effector Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Stocks That Hit 52-Week Lows On Monday
July 25, 2022
On Monday, 100 companies reached new 52-week lows.
Via
Benzinga
eFFECTOR's Cancer Therapy Achieves Two Partial Responses In Early-Stage Study
June 06, 2022
Via
Benzinga
Analyst Ratings For eFFECTOR Therapeutics
January 25, 2022
Analysts have provided the following ratings for eFFECTOR Therapeutics (NASDAQ:...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 20, 2022
Via
Benzinga
5 Value Stocks In The Healthcare Sector
July 18, 2022
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...
Via
Benzinga
4 Stocks Under $2 Insiders Are Aggressively Buying: NEXGEL, eFFECTOR Therapeutics And More
June 28, 2022
U.S. crude oil futures traded higher by over 1% on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
April 18, 2022
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
Analyst Ratings For eFFECTOR Therapeutics
March 17, 2022
Over the past 3 months, 4 analysts have published their opinion on eFFECTOR Therapeutics (NASDAQ:EFTR) stock. These analysts are typically employed by large Wall Street banks and...
Via
Benzinga
83 Biggest Movers From Yesterday
June 09, 2022
Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly...
Via
Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
June 08, 2022
Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million buyback.
Via
Benzinga
eFFECTOR Therapeutics's Return On Capital Employed Overview
March 17, 2022
According to Benzinga Pro, during Q4, eFFECTOR Therapeutics (NASDAQ:EFTR) earned $19.05 million, a 114.54% increase from the preceding quarter. eFFECTOR Therapeutics's sales...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 26, 2022
During Wednesday's morning session, 34 stocks hit new 52-week lows. Things to Consider About Today's 52-Week Lows: Illumina (NASDAQ:ILMN) was the biggest company...
Via
Benzinga
95 Biggest Movers From Yesterday
June 07, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 15, 2022
Tuesday's session saw 95 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 08, 2022
Tuesday's session saw 109 companies set new 52-week lows. Interesting Points From Today's 52-Week Highs And Lows: The largest company in terms of market cap...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
January 25, 2022
On Tuesday, 88 companies set new 52-week lows. Interesting Highlights From Today's 52-Week Lows: Credit Suisse Group (NYSE:CS) was the largest, in terms of market cap...
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
January 25, 2022
Needham cut Medtronic plc (NYSE:MDT) price target f...
Via
Benzinga
eFFECTOR Secures $50M Funding From Lincoln Park Capital
January 25, 2022
eFFECTOR Therapeutics Inc (NASDAQ: EFTR) entered into an investment agreement with Lincoln Park Capital for up to $50 million over 36 months. The Company said...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 29, 2021
Gainers Biofrontera (NASDAQ:
Via
Benzinga
60 Biggest Movers From Yesterday
December 07, 2021
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 200.4% to close at $15.05 on Monday after the company announced the commencement of a formal process to explore...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 06, 2021
Gainers Adicet Bio (NASDAQ:ACET) shares i...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2021
November 09, 2021
Upgrades JP Morgan upgraded the previous rating for New Relic Inc (NYSE:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021
October 12, 2021
Upgrades For Callaway Golf Co (NYSE:ELY), Compass ...
Via
Benzinga
46 Biggest Movers From Yesterday
October 12, 2021
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Monday's Intraday Session
October 11, 2021
Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares increased by 92.43% to $35.1 during Monday's regular session. Trading volume for this security as of 12:30 EST is...
Via
Benzinga
28 Stocks Moving In Monday's Mid-Day Session
October 11, 2021
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares surged 85% to $33.78. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical...
Via
Benzinga
Exposures
Product Safety
28 Stocks Moving In Friday's Mid-Day Session
October 08, 2021
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares climbed 60.8% to $31.51. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 08, 2021
Gainers ChemoCentryx (NASDAQ:CCXI) shares rose 77.65% to $34.82 during Friday's pre-market session. The company's market cap stands at $2.4 billion. eFFECTOR...
Via
Benzinga
eFFECTOR Therapeutics Stock Gains On Encouraging Preclinical Zotatifin Data In Breast Cancer
October 08, 2021
eFFECTOR Therapeutics Inc (NASDAQ: EFTR), in collaboration with Baylor College of Medicine, announced the presentation of new positive data for zotatifin in...
Via
Benzinga
18 Stocks Moving in Friday's Pre-Market Session
October 08, 2021
Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) rose 25.5% to $14.41 in pre-market trading after the company, in collaboration with investigators at Baylor College of Medicine...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.